10-QPeriod: Q1 FY2014

Elevance Health, Inc. Quarterly Report for Q1 Ended Mar 31, 2014

Filed April 30, 2014For Securities:ELV

Summary

Elevance Health, Inc. (formerly WellPoint, Inc.) reported its first quarter 2014 financial results, showing a slight increase in total operating revenue to $17.64 billion, up 1.2% year-over-year, driven by growth in its Government Business segment, particularly Medicaid, and increases in premium rates across various segments. However, net income saw a notable decrease of 20.8% to $701 million, resulting in diluted earnings per share (EPS) of $2.40, down from $2.89 in the prior year. The decline in profitability was primarily attributed to increased costs associated with healthcare reform, including the new non-tax deductible Health Insurance Provider Fee (HIP Fee), and shifts in product mix within the Commercial and Specialty Business segment. Despite the profitability dip, the company demonstrated strong operating cash flow of $1.39 billion, a significant increase from the prior year, indicating robust cash generation from its core operations. Management highlighted a strategic focus on its core Commercial and Specialty and Government Business segments, evidenced by the divestiture of its 1-800 CONTACTS business in January 2014.

Financial Statements
Beta
Revenue$17.86B
SG&A Expenses$2.86B
Operating Income$1.12B
Interest Expense$146.20M
Net Income$701.00M
EPS (Basic)$2.46
EPS (Diluted)$2.40
Shares Outstanding (Basic)284.90M
Shares Outstanding (Diluted)292.60M

Key Highlights

  • 1Total operating revenue increased 1.2% to $17.64 billion in Q1 2014 compared to Q1 2013.
  • 2Net income decreased by 20.8% to $701 million in Q1 2014.
  • 3Diluted EPS decreased to $2.40 in Q1 2014 from $2.89 in Q1 2013.
  • 4Operating cash flow significantly increased to $1.39 billion in Q1 2014.
  • 5The company divested its 1-800 CONTACTS business in January 2014.
  • 6Selling, general, and administrative expenses increased by 22.9%, largely due to new healthcare reform fees.
  • 7Total medical membership increased by 3.2% to 36.9 million.

Frequently Asked Questions

The decrease in net income was primarily driven by increased costs associated with the Patient Protection and Affordable Care Act (ACA), specifically the non-tax deductible Health Insurance Provider Fee (HIP Fee), and shifts in the product portfolio mix within the Commercial and Specialty Business segment. Additionally, changes in premium rates and membership mix impacted profitability.

Total medical membership grew by 3.2% year-over-year to 36.9 million. Growth was strong in self-funded membership (+12.2%) and Local Group (+4.4%), while fully-insured membership declined (-8.5%), partly due to the New York State contract conversion and Medicare business repositioning.

The non-tax deductible HIP Fee, effective January 1, 2014, had a significant impact on profitability. The company estimated its portion of the fee for 2014 to be approximately $920 million and recognized $230 million in general and administrative expenses related to the fee in the first quarter of 2014, contributing to the higher expense ratio.

A key strategic action was the divestiture of its 1-800 CONTACTS business and related assets in January 2014, aligning with its focus on core growth opportunities in the Commercial and Specialty Business and Government Business segments. The company also continued its share repurchase program, repurchasing approximately $1.26 billion of its common stock.